Back

Cresco Labs Inc

Ticker: CRLBF ISIN: CA22587M1068
Add to portfolio Portfolio analysis in 2min
Stock Small-cap High beta
Market cap
$384.03M
Forward P/E
105.26
Profit margin
-9.19%
Revenue growth QoQ
-3.80%
Beta
1.99
$0.73 -0.68%
Price as of 2026-08-27 · OTCQX

Performance by timeframe

Rolling returns
1 Month +14.49%
6 Months -25.76%
1 Year -50.34%
5 Years -40.54% p.a.-92.55%
Since inception -21.88% p.a.-85.19%
Calendar year returns
YTD -40.24%
2025 +34.57%
2024 -32.60%
2023 -24.67%
2022 -73.01%
2021 -32.39%

Key stats

Market cap
384.03M
Beta
1.99
52-week range
1.02 - 2.65
50-day MA
1.47
200-day MA
1.74
Section 1

Business overview

Company profile data from fundamentals.

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.

Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Country United States
Exchange OTCQX
Section 2

Financial quality

Above-average volatility

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE -14.17%
ROA 5.22%
Profit margin -9.19%
Operating margin 15.94%
Revenue/share TTM 2.14
Revenue TTM 733.45M
EBITDA 181.70M
Gross profit TTM 407.92M
Beta 1.99

Valuation

Trailing P/E 0.00
Forward P/E 105.26
P/B 0.84
P/S 0.52
EV/EBITDA 7.00
EV/Revenue 1.25
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) -0.22
Quarterly earnings growth 0.00%
Revenue TTM 733.45M
Reported quarters 26
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Forward annual div. yield 0.00%
Split factor 1:812
Last split date 2018-12-03
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Ownership & short interest

Shares outstanding 330.05M
Shares float 326.49M
Institutional ownership 5.50%
Insider ownership 65.50%
Short ratio 0.00

Details

Instrument metadata and source update timestamps.

Symbol CRLBF
Name Cresco Labs Inc
Asset type STOCK
Exchange OTCQX
Currency USD
ISIN CA22587M1068
Country USA
Code + exchange CRLBF.OTCQX
Fundamentals updated 2024-12-04

The information provided on this platform is for informational purposes only and should not be considered as financial or investment advice. Insightfolio does not provide investment advice, personalized recommendations, or guidance regarding the purchase, holding, or sale of financial assets. The tools and content are intended for educational purposes only and are not tailored to individual circumstances, financial needs, or objectives.

Insightfolio assumes no liability for the accuracy, completeness, or reliability of the information presented. Users are solely responsible for verifying the information and making independent decisions based on their own research and careful consideration. Use of the platform should not replace consultation with qualified financial professionals.

Investments involve risks. Users should be aware that the value of investments may fluctuate and that past performance is not an indicator of future results. Investment decisions should be based on personal financial goals, risk tolerance, and independent evaluation of relevant information.

Insightfolio does not endorse or guarantee the suitability of any particular financial product, security, or strategy. Any projections, forecasts, or hypothetical scenarios presented on the platform are for illustrative purposes only and are not guarantees of future outcomes.

By accessing the services, information, or content offered by Insightfolio, users acknowledge and agree to these terms of the disclaimer. If you do not agree to these terms, please do not use our platform.

Instrument logos provided by Elbstream.